- Tytuł:
- Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.
- Autorzy:
- Źródło:
- Cancer medicine [Cancer Med] 2014 Jun; Vol. 3 (3), pp. 603-12. Date of Electronic Publication: 2014 Feb 27.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Chemotherapy, Adjuvant*
Doxorubicin/*administration & dosage
Epirubicin/*administration & dosage
Sarcoma/*drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols ; Disease-Free Survival ; Doxorubicin/adverse effects ; Epirubicin/adverse effects ; Female ; Humans ; Ifosfamide/administration & dosage ; Male ; Middle Aged ; Risk Factors ; Sarcoma/pathology
Czasopismo naukowe